SPIN Unprocessed July 10, 2026 ai_technology finance
Virax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross Proceeds
View original on prnewswire.comOverview
LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par...
SpinGraph analysis pending — check back after processing.
Ask AI about this story
Opens with the SpinGraph .md URL and structured context — one click, prompt included.
More from PR Newswire Financial Services
View all →- blueharbor bank Reports Second Quarter 2026 Net Income
- TUSK Practice Sales Assesses the State of the Dental Industry in Its Q3 2026 Dental Market Report
- Aon Announces Second-Quarter 2026 Earnings Release and Conference Call Date
- Aon Announces Quarterly Cash Dividend
- ARES DYNAMIC CREDIT ALLOCATION FUND DECLARES A MONTHLY DISTRIBUTION OF $0.1125 PER SHARE
- AMH Announces Dates of Second Quarter 2026 Earnings Release and Conference Call
Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO